Search

everythinglearnresearchcommunity

for

Search:↓

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Inflammation damages sweat ducts, causing sweat gland injury.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Type 1 diabetes may cause certain autoimmune diseases in Europeans.

A girl with type 1 diabetes developed a serious eye condition very early, suggesting the need for earlier eye checks and that early treatment can work well.

Vitiligo and alopecia areata might be early signs of Type 1 Diabetes.

25% of premenopausal women with Type 1 diabetes have undiagnosed androgen excess disorders.

A 24-year-old man developed both alopecia areata universalis and type 1 diabetes at the same time, which is rare.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Type 1 diabetes patients often have other autoimmune diseases, which complicate their care.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Wnt-signaling is regulated differently in skin cells and immune responses during wound healing.

Laser treatment shows promise for hair growth, but needs further research.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Consider NF1 in newborns with rare congenital anomalies.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Minoxidil improved hair growth in a child with a rare genetic disorder.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

A new microneedle treatment shows promise for better hair regrowth in androgenetic alopecia.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Measuring 24-OHase induction helps identify defects in vitamin D processing and predict treatment response.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

TCHHL1 is a protein important for hair growth, found in hair follicles.

A new compound shows promise as a topical treatment for hair loss.

DDR-II hair follicle cells don't respond to 1, 25-dihydroxyvitamin D3, aiding diagnosis.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.